2
12
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T38269 | Purfalcamine | ||
Purfalcamine is an orally active, selective Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) inhibitor with an IC50 of 17 nM and an EC50 of 230 nM. Purfalcamine has antimalarial activity and causes malaria parasites developmental arrest at the schizont stage[1][2]. Purfalcamine has low activity against Toxoplasma gondii calcium-dependent protein kinase 3 (TgCDPK3)[1]. Purfalcamine (225, 450 nM) has no effect on the parasitemia in the first 32 hours. After about 40 hours, paras... | |||
T77122 |
Praluzatamab
|
Others | Others |
Praluzatamab 是一种靶向活化白细胞粘附分子 (ALCAM/CD116) 的单克隆抗体。Praluzatamab 是 Praluzatamab ravtansine 的裸抗, 可用于合成抗体活性分子偶联物(Praluzatamab ravtansine)。Praluzatamab 可用于研究研究乳腺癌。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPK-00339 |
ALCAM Protein, Mouse, Recombinant (His & Avi), Biotinylated
CD6L,ALCAM,MEMD,KG-CAM,CD166 |
Mouse | HEK293 Cells |
Brain metastasis (BM) in non-small-cell lung cancer (NSCLC) has a very poor prognosis. Recent studies have demonstrated the importance of cell adhesion molecules in tumor metastasis.Elevated levels of ALCAM expression promote BM formation in NSCLC through increased tumor cell dissemination and interaction with the brain endothelial cells. Therefore, ALCAM could be targeted to reduce the occurrence of BM. ALCAM Protein, Mouse, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian... | |||
TMPK-00340 |
ALCAM Protein, Human, Recombinant (His & Avi), Biotinylated
CD166,CD6L,KG-CAM,ALCAM,MEMD |
Human | HEK293 Cells |
Brain metastasis (BM) in non-small-cell lung cancer (NSCLC) has a very poor prognosis. Recent studies have demonstrated the importance of cell adhesion molecules in tumor metastasis.Elevated levels of ALCAM expression promote BM formation in NSCLC through increased tumor cell dissemination and interaction with the brain endothelial cells. Therefore, ALCAM could be targeted to reduce the occurrence of BM. ALCAM Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian... | |||
TMPK-00341 |
ALCAM Protein (Primary Amine Labeling), Human, Recombinant (His), Biotinylated
ALCAM,KG-CAM,MEMD,CD166,CD6L |
Human | HEK293 Cells |
Brain metastasis (BM) in non-small-cell lung cancer (NSCLC) has a very poor prognosis. Recent studies have demonstrated the importance of cell adhesion molecules in tumor metastasis.Elevated levels of ALCAM expression promote BM formation in NSCLC through increased tumor cell dissemination and interaction with the brain endothelial cells. Therefore, ALCAM could be targeted to reduce the occurrence of BM. ALCAM Protein (Primary Amine Labeling), Human, Recombinant (His), Biotinylated is expressed ... | |||
TMPY-01578 |
CD166/ALCAM Protein, Human, Recombinant (His)
activated leukocyte cell adhesion molecule,CD166,MEMD |
Human | HEK293 Cells |
CD166/ALCAM Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 57.4 kDa and the accession number is Q13740-1. | |||
TMPJ-00339 |
ALCAM Protein, Mouse, Recombinant (hFc)
CD6 ligand,CD166 antigen,CD6L,activated leucocyte cell adhes... |
Mouse | HEK293 Cells |
Activated leukocyte cell adhesion molecule (ALCAM), also named as CD166 and MEMD, is a typeI transmembrane glycoprotein of immunoglobulin superfamily, which mediates homotypic and heterotypic interactions between cells. ALCAM interacts with high affinity with CD6 molecule but weaker homotypic (ALCAM–ALCAM) interactions have also been described. ALCAM–CD6 interactions play an important role in the maintenance of T cell activation, proliferation as well as in formation of immune synapse between an... | |||
TMPY-03912 |
CD166/ALCAM Protein, Rat, Recombinant (hFc)
activated leukocyte cell adhesion molecule |
Rat | HEK293 Cells |
CD166/ALCAM Protein, Rat, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 83.1 kDa and the accession number is O35112. | |||
TMPY-05484 |
CD166/ALCAM Protein, Human, Recombinant (hFc)
MEMD,activated leukocyte cell adhesion molecule,CD166 |
Human | HEK293 Cells |
CD166/ALCAM Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 82.7 kDa and the accession number is Q13740-1. | |||
TMPY-02936 |
CD166/ALCAM Protein, Rat, Recombinant (His)
activated leukocyte cell adhesion molecule |
Rat | HEK293 Cells |
CD166/ALCAM Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 57.5 kDa and the accession number is O35112. | |||
TMPY-03520 |
CD166/ALCAM Protein, Cynomolgus, Recombinant (His)
activated leukocyte cell adhesion molecule |
Cynomolgus | HEK293 Cells |
CD166/ALCAM Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 57.3 kDa and the accession number is G7NZQ8. | |||
TMPY-01031 |
CD166/ALCAM Protein, Mouse, Recombinant (His & hFc)
CD166,AI853494,MuSC,DM-GRASP,BEN,activated leukocyte cell ad... |
Mouse | HEK293 Cells |
CD166/ALCAM Protein, Mouse, Recombinant (His & hFc) is expressed in HEK293 mammalian cells with His and hFc tag. The predicted molecular weight is 84.2 kDa and the accession number is Q54AJ5. | |||
TMPY-00249 |
CD166/ALCAM Protein, Cynomolgus, Recombinant (hFc)
activated leukocyte cell adhesion molecule |
Cynomolgus | HEK293 Cells |
CD166/ALCAM Protein, Cynomolgus, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 82.9 kDa and the accession number is F7E9U2. | |||
TMPY-01153 |
CD166/ALCAM Protein, Mouse, Recombinant (His)
MuSC,CD166,SC1,activated leukocyte cell adhesion molecule,DM... |
Mouse | HEK293 Cells |
CD166/ALCAM Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 57.7 kDa and the accession number is Q54AJ5. |